Glaukos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
1,094
Employees1,094
Headquarters
Aliso Viejo, California
HeadquartersAliso Viejo, California
Founded
1998
Founded1998
Employees
1,094
Employees1,094

GKOS Key Statistics

Market cap
6.85B
Market cap6.85B
Price-Earnings ratio
-35.76
Price-Earnings ratio-35.76
Dividend yield
Dividend yield
Average volume
613.22K
Average volume613.22K
High today
$129.00
High today$129.00
Low today
$113.00
Low today$113.00
Open price
$117.62
Open price$117.62
Volume
1.13M
Volume1.13M
52 Week high
$130.23
52 Week high$130.23
52 Week low
$73.16
52 Week low$73.16

Stock Snapshot

As of today, Glaukos(GKOS) shares are valued at $129.00. The company's market cap stands at 6.85B, with a P/E ratio of -35.76.

On 2026-04-29, Glaukos(GKOS) stock traded between a low of $113.00 and a high of $129.00. Shares are currently priced at $129.00, which is +14.2% above the low and 0.0% below the high.

Glaukos(GKOS) shares are trading with a volume of 1.13M, against a daily average of 613.22K.

During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $130.23 at its peak.

During the past year, Glaukos(GKOS) stock moved between $73.16 at its lowest and $130.23 at its peak.

GKOS News

TipRanks 2h
Glaukos reports Q1 EPS (18c), consensus (28c)

Reports Q1 revenue $150.6M, consensus $137.0M. “Our record first quarter results reflect successful global execution across our key global commercial and develo...

TipRanks 3h
Glaukos Boosts Outlook After Strong First-Quarter 2026 Results

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

93%

of 14 ratings
Buy
92.9%
Hold
7.1%
Sell
0%

People also own

Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.